血清IgE水平高的特应性皮炎患者的低剂量抗IgE治疗 - Suppr

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

作者信息

Belloni Benedetta, Ziai Mahzad, Lim Annick, Lemercier Brigitte, Sbornik Martin, Weidinger Stephan, Andres Christian, Schnopp Christina, Ring Johannes, Hein Rüdiger, Ollert Markus, Mempel Martin

出版信息

J Allergy Clin Immunol. 2007 Nov;120(5):1223-5. doi: 10.1016/j.jaci.2007.08.060. Epub 2007 Oct 22.

DOI:10.1016/j.jaci.2007.08.060

PMID:17936892

Abstract

摘要

相似文献

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

J Allergy Clin Immunol. 2007 Nov;120(5):1223-5. doi: 10.1016/j.jaci.2007.08.060. Epub 2007 Oct 22.

Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema.

J Investig Allergol Clin Immunol. 2011;21(5):416-7.

Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.

South Med J. 2010 Jun;103(6):554-8. doi: 10.1097/SMJ.0b013e3181de0cf6.

Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E.

Acta Derm Venereol. 2013 Mar 27;93(2):206-8. doi: 10.2340/00015555-1442.

Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.

Allergy Asthma Proc. 2008 Sep-Oct;29(5):530-7. doi: 10.2500/aap.2008.29.3160.

Omalizumab for patients with severe and therapy-refractory atopic eczema?

Curr Allergy Asthma Rep. 2008 May;8(3):179-80. doi: 10.1007/s11882-008-0029-3.

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):243-8. doi: 10.1016/S1081-1206(10)61495-0.

Anti-CD20 (rituximab) treatment for atopic eczema.

J Allergy Clin Immunol. 2008 Jun;121(6):1515-6; author reply 1516-7. doi: 10.1016/j.jaci.2008.03.007. Epub 2008 Apr 14.

Omalizumab treatment in severe adult atopic dermatitis.

Asian Pac J Allergy Immunol. 2011 Dec;29(4):357-60.

[Therapeutic possibilities and clinical effects of IgE level modulation in allergic diseases].

Pneumonol Alergol Pol. 2004;72(1-2):70-4.

引用本文的文献

European Guideline (EuroGuiDerm) on atopic eczema: Living update.

J Eur Acad Dermatol Venereol. 2025 Sep;39(9):1537-1566. doi: 10.1111/jdv.20639. Epub 2025 May 2.

Digitalising the past decades: automated ICD-10 coding of unstructured free text dermatological diagnoses.

BMC Health Serv Res. 2024 Oct 29;24(1):1297. doi: 10.1186/s12913-024-11761-y.

Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence.

World Allergy Organ J. 2021 Mar 19;14(3):100519. doi: 10.1016/j.waojou.2021.100519. eCollection 2021 Mar.

Systemic treatments for eczema: a network meta-analysis.

Cochrane Database Syst Rev. 2020 Sep 14;9(9):CD013206. doi: 10.1002/14651858.CD013206.pub2.

Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.

J Clin Apher. 2020 Jan;35(1):50-58. doi: 10.1002/jca.21759. Epub 2019 Nov 22.

Childhood atopic dermatitis: current developments, treatment approaches, and future expectations.

Turk J Med Sci. 2019 Aug 8;49(4):963-984. doi: 10.3906/sag-1810-105.

New insights into the utility of omalizumab.

J Allergy Clin Immunol. 2019 Mar;143(3):923-926.e1. doi: 10.1016/j.jaci.2019.01.016. Epub 2019 Jan 26.

The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry.

Postepy Dermatol Alergol. 2018 Oct;35(5):510-515. doi: 10.5114/ada.2018.77243. Epub 2018 Jul 19.

Systemic therapy of atopic dermatitis.

Allergol Select. 2017 Aug 4;1(1):1-8. doi: 10.5414/ALX01285E. eCollection 2017.

Atopic dermatitis-like skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes.

Exp Mol Med. 2018 Jun 13;50(6):1-9. doi: 10.1038/s12276-018-0104-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

J Allergy Clin Immunol. 2007 Nov;120(5):1223-5. doi: 10.1016/j.jaci.2007.08.060. Epub 2007 Oct 22.

Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema.

J Investig Allergol Clin Immunol. 2011;21(5):416-7.

Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.

South Med J. 2010 Jun;103(6):554-8. doi: 10.1097/SMJ.0b013e3181de0cf6.

Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E.

Acta Derm Venereol. 2013 Mar 27;93(2):206-8. doi: 10.2340/00015555-1442.

Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.

Allergy Asthma Proc. 2008 Sep-Oct;29(5):530-7. doi: 10.2500/aap.2008.29.3160.

Omalizumab for patients with severe and therapy-refractory atopic eczema?

Curr Allergy Asthma Rep. 2008 May;8(3):179-80. doi: 10.1007/s11882-008-0029-3.

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.

Ann Allergy Asthma Immunol. 2004 Sep;93(3):243-8. doi: 10.1016/S1081-1206(10)61495-0.

Anti-CD20 (rituximab) treatment for atopic eczema.

J Allergy Clin Immunol. 2008 Jun;121(6):1515-6; author reply 1516-7. doi: 10.1016/j.jaci.2008.03.007. Epub 2008 Apr 14.

Omalizumab treatment in severe adult atopic dermatitis.

Asian Pac J Allergy Immunol. 2011 Dec;29(4):357-60.

[Therapeutic possibilities and clinical effects of IgE level modulation in allergic diseases].

Pneumonol Alergol Pol. 2004;72(1-2):70-4.

引用本文的文献

European Guideline (EuroGuiDerm) on atopic eczema: Living update.

J Eur Acad Dermatol Venereol. 2025 Sep;39(9):1537-1566. doi: 10.1111/jdv.20639. Epub 2025 May 2.

Digitalising the past decades: automated ICD-10 coding of unstructured free text dermatological diagnoses.

BMC Health Serv Res. 2024 Oct 29;24(1):1297. doi: 10.1186/s12913-024-11761-y.

Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence.

World Allergy Organ J. 2021 Mar 19;14(3):100519. doi: 10.1016/j.waojou.2021.100519. eCollection 2021 Mar.

Systemic treatments for eczema: a network meta-analysis.

Cochrane Database Syst Rev. 2020 Sep 14;9(9):CD013206. doi: 10.1002/14651858.CD013206.pub2.

Single-use IgE-selective immunoadsorber column for the treatment of severe atopic dermatitis.

J Clin Apher. 2020 Jan;35(1):50-58. doi: 10.1002/jca.21759. Epub 2019 Nov 22.

Childhood atopic dermatitis: current developments, treatment approaches, and future expectations.

Turk J Med Sci. 2019 Aug 8;49(4):963-984. doi: 10.3906/sag-1810-105.

New insights into the utility of omalizumab.

J Allergy Clin Immunol. 2019 Mar;143(3):923-926.e1. doi: 10.1016/j.jaci.2019.01.016. Epub 2019 Jan 26.

The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry.

Postepy Dermatol Alergol. 2018 Oct;35(5):510-515. doi: 10.5114/ada.2018.77243. Epub 2018 Jul 19.

Systemic therapy of atopic dermatitis.

Allergol Select. 2017 Aug 4;1(1):1-8. doi: 10.5414/ALX01285E. eCollection 2017.

Atopic dermatitis-like skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes.

Exp Mol Med. 2018 Jun 13;50(6):1-9. doi: 10.1038/s12276-018-0104-3.

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献